Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease

New England Journal of Medicine

Volumn 346, Issue 13, 2002, Pages 967-974

  Herrington, David M ^a   Howard, Timothy D ^a   Hawkins, Gregory A ^a   Reboussin, David M ^a   Xu, Jianfeng ^a   Zheng, Siqun L ^a   Bridget Brosnihan, K ^a   Meyers, Deborah A ^a   Bleecker, Eugene R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; PLACEBO;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CHOLESTEROL, HDL; CORONARY DISEASE; DNA; ESTROGEN REPLACEMENT THERAPY; FEMALE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RECEPTORS, ESTROGEN; SEQUENCE ANALYSIS, DNA; TRIGLYCERIDES;

EID: 0037187926     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa012952     Document Type: Article

References (57)

1. Postmenopausal estrogen use and coronary atherosclerosis
2. How do we explain the clinical benefits of estrogen? From bedside to bench
3. A major locus influencing plasma high-density lipoprotein cholesterol levels in the San Antonio Family Heart Study: Segregation and linkage analyses
4. Candidate-gene studies of the atherogenic lipoprotein phenotype: A sib-pair linkage analysis of DZ women twins
5. The syndromes of androgen resistance
6. Aldosterone-receptor deficiency in pseudohypoaldosteronism
7. Vitamin D3-resistant fibroblasts have immunoassayable 1,25-dihydroxyvitamin D3 receptors
8. A new mechanism for steroid unresponsiveness: Loss of nuclear binding activity of a steroid hormone receptor
9. The Estrogen Replacement and Atherosclerosis (ERA) study: Study design and baseline characteristics of the cohort
10. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
11. Enzymatic determination of total serum cholesterol
12. Enzymatic determination of total cholesterol in serum
13. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor
14. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide
15. Sur un dosage rapide du cholesterol lié aux α- et aux β-lipoprotéines du sérum
16. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
17. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
18. Hepatic triglyceride lipase
19. Dinucleotide repeat polymorphism in the human estrogen receptor (ESR) gene
20. Molecular analysis of estrogen receptor alpha and beta in lupus patients
21. PvuII RFLP inside the human estrogen receptor gene
22. Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility
23. Single nucleotide poly-morphisms (SNPs) in the estrogen receptor gene and breast cancer susceptibility
24. Identification of a novel poly-morphism of estrogen receptor-alpha gene that is associated with calcium excretion in urine
25. Genomic organization of the human oestrogen receptor gene
26. Re: "Risk of miscarriage and a common variant of the estrogen receptor gene"
27. Genomic DNA analysis of the estrogen receptor gene in breast cancer
28. Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism
29. Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood
30. Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer
31. An estrogen receptor genetic polymorphism and the risk of primary and secondary recurrent spontaneous abortion
32. Association of bone mineral density with polymorphism of the estrogen receptor gene
33. Association of estrogen receptor-alpha genotypes with body mass index in normal healthy postmenopausal Caucasian women
34. Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis
35. Non-association of estrogen receptor genotypes with bone mineral density and bone turnover in Korean pre-, peri-, and postmenopausal women
36. Estrogen receptor variant and hypertension in women
37. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels
38. Association of serum low-density lipoprotein metabolism with oestrogen receptor gene polymorphisms in healthy children
39. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: A randomized controlled trial
40. Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS)
41. Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol
42. Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS): Treatment effects and relation to coronary angiographic progression
43. High-density lipoprotein cholesterol and cardiovascular disease: Four prospective American studies
44. Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: Safety of treatment, changes in risk factors, and incidence of coronary heart disease
45. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate
46. Oestrogen-receptor-alpha gene polymorphism affects response in bone mineral density to oestrogen in post-menopausal women
47. Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes
48. Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean post-menopausal women
49. Identification of an enhancer and an alternative promoter in the first intron of the α-fetoprotein gene
50. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells
51. Skipping of exon 14 and possible instability of both the mRNA and the resultant truncated protein underlie a common cholesteryl ester transfer protein deficiency in Japan
52. Mutations that alter RNA splicing of the human HPRT gene: A review of the spectrum
53. Variant estrogen and progesterone receptor messages in human vascular smooth muscle
54. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
55. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man